Dr. Reddy's Laboratories
RDY
12,78 €
Share price
0.41%
Change (1 day)
-15.74%
Change (1 year)
Categories
Revenue for Dr. Reddy's Laboratories (RDY)
Revenue in 2025 (TTM): €3.57 Billion
According to Dr. Reddy's Laboratories's latest financial reports the company's current revenue (TTM 
) is €3.32 Billion. In 2024 the company made a revenue of €3.55 Billion an increase over the revenue in the year 2023 that were of €2.96 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Dr. Reddy's Laboratories from 2002 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | €3.57 B | 0.45% |
| 2024 | €3.55 B | 19.8% |
| 2023 | €2.96 B | 7.22% |
| 2022 | €2.76 B | 12.04% |
| 2021 | €2.47 B | 21.08% |
| 2020 | €2.04 B | -5.84% |
| 2019 | €2.16 B | 14.73% |
| 2018 | €1.88 B | 3.02% |
| 2017 | €1.83 B | -9.36% |
| 2016 | €2.02 B | -8.51% |
| 2015 | €2.21 B | 14.28% |
| 2014 | €1.93 B | 21.38% |
| 2013 | €1.59 B | 10.12% |
| 2012 | €1.44 B | -0.14% |
| 2011 | €1.44 B | 22.5% |
| 2010 | €1.18 B | 10.8% |
| 2009 | €1.06 B | 5.92% |
| 2008 | €1.00 B | 15.2% |
| 2007 | €0.87 B | -7.25% |
| 2006 | €0.94 B | 116% |
| 2005 | €0.43 B | 34.6% |
| 2004 | €0.32 B | -3.5% |
| 2003 | €0.33 B | -3.98% |
| 2002 | €0.35 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | €54.06 B | 1,524.02% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | €14.38 B | 331.99% | 🇮🇱 Israel |
 GlaxoSmithKline GSK | €35.13 B | 955.24% | 🇬🇧 UK |
 Novartis NVS | €46.06 B | 1,283.76% | 🇨🇭 Switzerland |
 Sanofi SNY | €41.02 B | 1,132.34% | 🇫🇷 France |